
Novo Nordisk has raised its sales and operating outlook for 2021.
This comes after the firm ended Q3 with a 15 percent increase in net sales and a 19 percent increase in operating profits, measured in constant exchange rates (CER). For the first nine months of the year, Novo reports net revenue growth of 13 percent and an operating result growth of 12 percent.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app